Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users.

BACKGROUND The prevalences and correlates of non-viral injecting-related injuries and diseases (IRIDs) in Australian injecting drug users (IDUs) remain unknown. METHODS A cross-sectional survey of IDUs was conducted in six sites across Australia's eastern states to investigate IRID experience among Australian IDU. Correlates of IRIDs were explored using logistic and negative binomial regression analyses. RESULTS 393 IDUs were recruited. Lifetime experience of non-serious IRIDs was common (e.g., 'dirty hit' 68%); potentially serious and serious IRIDs were less commonly experienced (e.g., abscess 16%; gangrene <1%). Factors independently associated with potentially serious or serious IRIDs in the previous 12 months were: injecting in sites other than arms (Adjusted Odds Ratio 3.0, 95% confidence interval 1.7-5.4), injecting non-powder drug forms (5.0, 2.2-11.2), unstable accommodation (2.0, 1.1-3.5), being aged 25 years or older (4.3, 1.7-10.6) and not always washing hands before injection (9.3, 2.1-41.8). Factors independently associated with multiple IRIDs in the preceding 12 months were using three or more injecting sites (Adjusted Incidence Rate Ratio 1.5, 95% CI 1.1-2.0), injecting in sites other than arms (1.7, 1.3-2.2), using non-powder drug forms (1.9, 1.4-2.5), injecting daily or more often (1.7, 1.3-2.2), current pharmacotherapy experience (1.5, 1.1-1.9), and not always washing hands before injecting (1.9, 1.2-2.9). DISCUSSION Some IRIDs are widespread among Australian IDUs. Observed associations, particularly the protective effect of handwashing, have useful public health implications.

[1]  R. Hogg,et al.  Prevalence and correlates of abscesses among a cohort of injection drug users , 2005, Harm reduction journal.

[2]  D. Cranston,et al.  Patients in methadone maintenance treatment who inject methadone syrup: a preliminary study. , 2000, Drug and alcohol review.

[3]  B. Edlin,et al.  Soft tissue infections among injection drug users--San Francisco, California, 1996-2000. , 2001, MMWR. Morbidity and mortality weekly report.

[4]  M. Crossley Temperate pyomyositis in an injecting drug misuser. A difficult diagnosis in a difficult patient , 2003, Emergency medicine journal : EMJ.

[5]  R. Macrae,et al.  Gendered power dynamics and HIV risk in drug-using sexual relationships , 2000, AIDS care.

[6]  T. Templin,et al.  Chronic venous insufficiency in persons with a history of injection drug use. , 2001, Research in nursing & health.

[7]  B. Edlin,et al.  High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  T. Rhodes,et al.  Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. , 2006, Addiction.

[9]  P. Giudice Cutaneous complications of intravenous drug abuse. , 2004 .

[10]  A. Morrison,et al.  Injecting-related harm and treatment-seeking behaviour among injecting drug users. , 1997, Addiction.

[11]  P. Allen,et al.  Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species , 2005, The Medical journal of Australia.

[12]  D. Looke,et al.  Role of the lemon in disseminated candidiasis of heroin abusers , 1984, The Medical journal of Australia.

[13]  N. Clark,et al.  Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? , 2005, Addiction.

[14]  J. Tsao,et al.  Presentation, Diagnosis, and Management of Arterial Mycotic Pseudoaneurysms in Injection Drug Users , 2002, Annals of vascular surgery.

[15]  N. Cassoux,et al.  Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex) , 2002, The British journal of ophthalmology.

[16]  G. Feeney,et al.  Digit loss following misuse of temazepam , 2002, The Medical journal of Australia.

[17]  D. Goldberg,et al.  Update: Clostridium novyi and unexplained illness among injecting-drug users--Scotland, Ireland, and England, April-June 2000. , 2000, MMWR. Morbidity and mortality weekly report.

[18]  L. Topp,et al.  Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs , 2008, Australian and New Zealand journal of public health.

[19]  D. Vugia,et al.  Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  R. Bruno,et al.  Tasmanian Drug Trends 2015. Findings from the Illicit Drug Reporting System (IDRS) , 2000 .

[21]  G. Pawelec Immunity and ageing in man , 2006, Experimental Gerontology.

[22]  J. Montaner,et al.  Changes in injecting practices associated with the use of a medically supervised safer injection facility. , 2007, Journal of public health.

[23]  B. Lloyd,et al.  Qld Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS) , 2003 .

[24]  D. O’Briain,et al.  Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin? , 2003, Archives of pathology & laboratory medicine.

[25]  Shane Darke,et al.  The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. , 2002, Drug and alcohol review.

[26]  T. Rhodes,et al.  Groin injecting in the context of crack cocaine and homelessness: From ‘risk boundary’ to ‘acceptable risk’? , 2006 .

[27]  A. Ritter,et al.  Paying research participants: a study of current practices in Australia , 2005, Journal of Medical Ethics.

[28]  S. Darke,et al.  Physical injecting sites among injecting drug users in Sydney, Australia. , 2001, Drug and alcohol dependence.

[29]  L. Maher,et al.  Risk behaviours of young Indo‐Chinese injecting drug users in Sydney and Melbourne , 2001, Australian and New Zealand journal of public health.

[30]  J. Murie,et al.  Vascular complications of injecting drug misuse , 1996, The British journal of surgery.

[31]  G. Feeney,et al.  Groin tissue necrosis requiring skin graft following parenteral abuse of buprenorphine tablets. , 2003, Drug and alcohol review.

[32]  P. Higgs,et al.  Vulnerability among Vietnamese illicit drug users in Australia: challenges for change , 2002 .

[33]  S. Allsop,et al.  Managing alcohol‐related problems among Indigenous Australians: what the literature tells us , 2010, Australian and New Zealand journal of public health.

[34]  J. Brazier,et al.  Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom , 2005, Epidemiology and Infection.

[35]  R. Coutinho,et al.  Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. , 1996, Journal of clinical epidemiology.

[36]  D. Passaro,et al.  Wound botulism associated with black tar heroin among injecting drug users. , 1998, JAMA.

[37]  N. Hunt,et al.  The safer injecting briefing: an easy to use comprehensive reference guide to promoting safer injecting. , 1998 .